Sing Sing Way, MD, PhD, a leading expert in understanding how the immune system responds to pregnancy, was selected as part of the academy’s 2025 class of members.

Results of the DYNAMIC-III trial, a multi-institutional phase II/III international study conducted at Johns Hopkins and about 20 sites in Australia and Canada, showed that by using ctDNA to guide treatment, patients who tested negative for ctDNA following surgery received less chemotherapy and had fewer hospitalizations and treatment side effects. The study was published Oct. 20 in Nature Medicine and presented at the European Society for Medical Oncology meeting in Berlin, Germany. The work was partly supported by the National Institutes of Health.

BUFFALO, NY – October 20, 2025 – A new research paper was published in Volume 16 of Oncotarget on October 16, 2025, titled “Widespread folate receptor expression in pediatric and adolescent solid tumors – opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine.”

The National Academy of Medicine announced the election of Karel Svoboda, Ph.D., executive vice president and director of Allen Institute’s Neural Dynamics moonshot, and Jay Shendure, M.D./Ph.D., lead scientific director of the collaborative Seattle Hub for Synthetic Biology and professor at the University of Washington School of Medicine. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes leaders who have demonstrated outstanding professional achievement and made lasting contributions to the advancement of the medical sciences, health care, and public health.